Regal Assets Analytics

Call Us: (800) 891-1526

M - F 8AM to 4PM ET

SanaCurrents Updates

Tricida to report 2Q earnings on August 5; SanaCurrents expects eventual FDA approval of veverimer

By |2020-08-03T15:29:52-04:00August 3rd, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|Tags: |

Tricida (NASDAQ:TCDA) shares slid about 40% last month when the [...]

Gritstone, BioXcel Expect to Report Catalysts in July 2020; 2Q SanaCurrents Update

By |2020-07-07T07:48:32-04:00July 6th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents, SanaCurrents Updates|

Gritstone Oncology (NASDAQ:GRTS) plans to hold a conference call and [...]

New Magenta Catalyst MGTA-145 After Company Drops MGTA-456 Phase II Trial

By |2020-07-06T10:23:39-04:00June 26th, 2020|Categories: Bill Langbein, SanaCurrents, SanaCurrents Probability Sentiment, SanaCurrents Updates|Tags: |

Shares of Magenta Therapeutics (NASDAQ: MGTA) declined 22% on June [...]

Selecta Licenses Away Promising Gout Drug; SanaCurrents Suspending Coverage

By |2020-07-06T10:24:12-04:00June 12th, 2020|Categories: Bill Langbein, Healthcare, Pharmaceutical & Biotechnology, SanaCurrents Updates|Tags: , , |

After the market closed on June 11, Selecta Biosciences, Inc. [...]

Harpoon (HARP) Snares Last Minute Share Surge After Positive Phase I Data

By |2020-06-03T10:02:13-04:00May 30th, 2020|Categories: Bill Langbein, Insights, SanaCurrents Updates|Tags: |

Harpoon Therapeutics (NASDAQ:HARP), a biotechnology company developing an antibody platform [...]

Avadel Shares Stable After Nice Run; Cassava Shares Languish on Alzheimer’s Blues

By |2020-05-21T14:33:03-04:00May 18th, 2020|Categories: Bill Langbein, Insights, SanaCurrents Updates|Tags: , |

Avadel Pharmaceuticals plc (NASDAQ:AVDL) recently announced positive phase III trial [...]